116 related articles for article (PubMed ID: 7925906)
1. The levels of clarithromycin and its 14-hydroxy metabolite in the lung.
Honeybourne D; Kees F; Andrews JM; Baldwin D; Wise R
Eur Respir J; 1994 Jul; 7(7):1275-80. PubMed ID: 7925906
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid.
Kikuchi E; Yamazaki K; Kikuchi J; Hasegawa N; Hashimoto S; Ishizaka A; Nishimura M
Respirology; 2008 Mar; 13(2):221-6. PubMed ID: 18339019
[TBL] [Abstract][Full Text] [Related]
3. Intrapulmonary pharmacokinetics of clarithromycin and of erythromycin.
Conte JE; Golden JA; Duncan S; McKenna E; Zurlinden E
Antimicrob Agents Chemother; 1995 Feb; 39(2):334-8. PubMed ID: 7726492
[TBL] [Abstract][Full Text] [Related]
4. Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects.
Gotfried MH; Danziger LH; Rodvold KA
J Antimicrob Chemother; 2003 Sep; 52(3):450-6. PubMed ID: 12888589
[TBL] [Abstract][Full Text] [Related]
5. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
Togami K; Chono S; Morimoto K
J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
[TBL] [Abstract][Full Text] [Related]
6. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers.
Rodvold KA; Gotfried MH; Danziger LH; Servi RJ
Antimicrob Agents Chemother; 1997 Jun; 41(6):1399-402. PubMed ID: 9174209
[TBL] [Abstract][Full Text] [Related]
7. The concentrations of clarithromycin and its 14-hydroxy metabolite in sputum of patients with bronchiectasis following single dose oral administration.
Tsang KW; Roberts P; Read RC; Kees F; Wilson R; Cole PJ
J Antimicrob Chemother; 1994 Feb; 33(2):289-97. PubMed ID: 8182010
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of clarithromycin.
Rodvold KA
Clin Pharmacokinet; 1999 Nov; 37(5):385-98. PubMed ID: 10589373
[TBL] [Abstract][Full Text] [Related]
9. Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.
Conte JE; Golden J; Duncan S; McKenna E; Lin E; Zurlinden E
Antimicrob Agents Chemother; 1996 Jul; 40(7):1617-22. PubMed ID: 8807050
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of clarithromycin and active metabolite in the epithelial lining fluid of patients with Mycobacterium avium complex pulmonary disease.
Hasegawa N; Nishimura T; Watabnabe M; Tasaka S; Nakano Y; Yamazaki K; Hashimoto S; Nishimura M; Ishizaka A
Pulm Pharmacol Ther; 2009 Jun; 22(3):190-3. PubMed ID: 19061965
[TBL] [Abstract][Full Text] [Related]
11. Penetration of clarithromycin into lung tissues from patients undergoing lung resection.
Fish DN; Gotfried MH; Danziger LH; Rodvold KA
Antimicrob Agents Chemother; 1994 Apr; 38(4):876-8. PubMed ID: 8031063
[TBL] [Abstract][Full Text] [Related]
12. Oral absorption of clarithromycin is nearly abolished by chronic comedication of rifampicin in foals.
Peters J; Block W; Oswald S; Freyer J; Grube M; Kroemer HK; Lämmer M; Lütjohann D; Venner M; Siegmund W
Drug Metab Dispos; 2011 Sep; 39(9):1643-9. PubMed ID: 21690264
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages.
Ikawa K; Kikuchi E; Kikuchi J; Nishimura M; Derendorf H; Morikawa N
J Clin Pharm Ther; 2014 Aug; 39(4):411-7. PubMed ID: 24661290
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of clarithromycin and concentrations in body fluids and bronchoalveolar cells of foals.
Womble AY; Giguère S; Lee EA; Vickroy TW
Am J Vet Res; 2006 Oct; 67(10):1681-6. PubMed ID: 17014316
[TBL] [Abstract][Full Text] [Related]
15. Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages.
Togami K; Chono S; Morimoto K
Biopharm Drug Dispos; 2011 Oct; 32(7):389-97. PubMed ID: 21812004
[TBL] [Abstract][Full Text] [Related]
16. Clarithromycin is absorbed by an intestinal uptake mechanism that is sensitive to major inhibition by rifampicin: results of a short-term drug interaction study in foals.
Peters J; Eggers K; Oswald S; Block W; Lütjohann D; Lämmer M; Venner M; Siegmund W
Drug Metab Dispos; 2012 Mar; 40(3):522-8. PubMed ID: 22170330
[TBL] [Abstract][Full Text] [Related]
17. The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin- and erythromycin-resistant Streptococcus pneumoniae.
Martin SJ; Garvin CG; McBurney CR; Sahloff EG
J Antimicrob Chemother; 2001 May; 47(5):581-7. PubMed ID: 11328768
[TBL] [Abstract][Full Text] [Related]
18. Disposition of oral telithromycin in foals and in vitro activity of the drug against macrolide-susceptible and macrolide-resistant Rhodococcus equi isolates.
Javsicas LH; Giguère S; Womble AY
J Vet Pharmacol Ther; 2010 Aug; 33(4):383-8. PubMed ID: 20646201
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of gatifloxacin after a single oral dose in healthy young adult subjects and adult patients with chronic bronchitis, with a comparison of drug concentrations obtained by bronchoscopic microsampling and bronchoalveolar lavage.
Kikuchi J; Yamazaki K; Kikuchi E; Ishizaka A; Nishimura M
Clin Ther; 2007 Jan; 29(1):123-30. PubMed ID: 17379052
[TBL] [Abstract][Full Text] [Related]
20. Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin.
Patel KB; Xuan D; Tessier PR; Russomanno JH; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 1996 Oct; 40(10):2375-9. PubMed ID: 8891147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
